Agenda - Combination products operational group, In vitro diagnostics (IVD) stream, 9 February 2026
Agenda - Combination products operational group, In vitro diagnostics (IVD) stream, 9 February 2026
Agenda - Combination products operational group, In vitro diagnostics (IVD) stream, 9 February 2026
Agenda - Combination products operational group, Medical devices (MD) stream, 12 February 2026
Webinar on the use of platform technologies in the non-clinical and clinical domains, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 2 March 2026, 09:25 (CET) to 2 March 2026, 12:15 (CET)
Overview of (invented) names reviewed in November 2025 by the Name Review Group (NRG) adopted at the CHMP meeting of 11 December 2025
Human medicines European public assessment report (EPAR): Rayvow, lasmiditan, Date of authorisation: 17/08/2022, Revision: 6, Status: Authorised
Medicine shortages and availability issues
Drug Shortages Global Regulatory Working Group
PSUSA/00003006/202503
Human medicines European public assessment report (EPAR): Insulin aspart Sanofi, insulin aspart, Date of authorisation: 25/06/2020, Revision: 7, Status: Authorised
Agenda - Webinar on the use of platform technologies in the non-clinical and clinical domains